Subcutaneous Implantable Microneedle System for the Treatment of Alzheimer’s Disease by Delivering Donepezil-Reference-Cited by-同舟云学术

Subcutaneous Implantable Microneedle System for the Treatment of Alzheimer’s Disease by Delivering Donepezil

Published:2022-12-01 Issue:12 Volume:23 Page:5330-5339
ISSN:1525-7797
Container-title:Biomacromolecules
language:en
Short-container-title:Biomacromolecules

Author:

Zhao Ze Qiang¹²,Liang Ling¹³,Hu Liu Fu¹²,He Yu Ting¹²,Jing Li Yue¹²,Liu Yue¹²,Chen Bo Zhi¹²^ORCID,Guo Xin Dong¹²⁴^ORCID

Affiliation:

1. State Key Laboratory of Organic-Inorganic Composites, Beijing University of Chemical Technology, Beijing 100029, China

2. Beijing Laboratory of Biomedical Materials, College of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing 100029, P.R. China

3. Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, Beijing 100029, P.R. China

4. High-Tech Research Institute, Beijing University of Chemical Technology, Beijing 100029, P.R. China

Funder

Ministry of Education of the People's Republic of China

Beijing University of Chemical Technology

National Natural Science Foundation of China

Ministry of Finance of the People's Republic of China

China-Japan Friendship Hospital

Publisher

American Chemical Society (ACS)

Subject

Materials Chemistry,Polymers and Plastics,Biomaterials,Bioengineering

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.biomac.2c01155

Reference40 articles.

1. Treatment of Alzheimer's Disease

2. Alzheimer's disease: strategies for disease modification

3. The neuropathological diagnosis of Alzheimer’s disease

4. Progress and perspectives of brain-targeting lipid-based nanosystems via the nasal route in Alzheimer’s disease

5. Endogenous Polyamines Reduce the Toxicity of Soluble Aβ Peptide Aggregates Associated with Alzheimer’s Disease

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implantable trilayer microneedle transdermal delivery system to enhance bioavailability and brain delivery of rivastigmine for Alzheimer treatment: A proof-of-concept study;European Journal of Pharmaceutics and Biopharmaceutics;2024-08

2. Microneedle-mediated drug delivery for neurological diseases;International Journal of Pharmaceutics;2024-08

3. Unlocking the potential of transdermal drug delivery;International Journal of Smart and Nano Materials;2024-06-15

4. Emerging hydrogel therapies for translating brain disease: Materials, mechanisms, and recent research;Materials Today Advances;2024-06

5. Nanomaterials-incorporated polymeric microneedles for wound healing applications;International Journal of Pharmaceutics;2024-06